Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2

Cell Biology International

Volumn 32, Issue 7, 2008, Pages 814-826

  Hashizume, Toshihiro ^a   Fukuda, Takayuki ^a   Nagaoka, Tadahiro ^a,b   Tada, Hiroko ^a   Yamada, Hidenori ^a   Watanabe, Kazuhide ^b   Salomon, David S ^b   Seno, Masaharu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EC 1; Endocytosis; ErbB2; Internalization; SKBr3; SKOv3

Indexed keywords

CLATHRIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GREEN FLUORESCENT PROTEIN; LIGAND; PEPTIDE;

ARTICLE; CELL LINE; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; INTERNALIZATION; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION;

BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CLATHRIN-COATED VESICLES; ENDOCYTOSIS; HUMANS; LIGANDS; PEPTIDES, CYCLIC; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; TRANSFERRIN;

EID: 44549087930     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.03.012     Document Type: Article

References (45)

1. Austin C.D., De Maziere A.M., Pisacane P.I., van Dijk S.M., Eigenbrot C., Sliwkowski M.X., et al. Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin. Mol Biol Cell 15 (2004) 5268-5282
2. Baselga J., Albanell J., Molina M.A., and Arribas J. Mechanism of action of trastuzumab and scientific update. Semin Oncol 28 (2001) 4-11
3. Baulida J., Kraus M.H., Alimandi M., Di Fiore P.P., and Carpenter G. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem 1 271 (1996) 5251-5257
4. Berchuck A., Kamel A., Whitaker R., Kerns B., Olt G., Kinney R., et al. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50 (1990) 4087-4091
5. Borg J.P., Marchetto S., Le B.A., Ollendorff V., Jaulin-Bastard F., Saito H., et al. ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat Cell Biol 2 (2000) 407-414
6. Cho H.S., Mason K., Ramyar K.X., Stanley A.M., Gabelli S.B., Denney D.W., et al. Structure of the extracellular region of HER2 alone and in complex with the herceptin fab. Nature 421 (2003) 756-760
7. Citri A., Skaria K.B., and Yarden Y. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp Cell Res 284 (2003) 54-65
8. Cuello M., Ettenberg S.A., Clark A.S., Keane M.M., Posner R.H., Nau M.M., et al. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res 61 (2001) 4892-4900
9. Djavadi-Ohaniance L., Goldberg M.E., and Friguet B. Measuring antibody affinity in solution. In: McCafferty J., Hoogenboom R., and Chiswell D.J. (Eds). Antibody engineering: A practical approach (1996), IRL Press, Oxford 77
10. Friedman L.M., Rinon A., Schechter B., Lyass L., Lavi S., Bacus S.S., et al. Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. Proc Natl Acad Sci USA 102 (2005) 1915-1920
11. Graus Porta D., Beerli R.R., Daly J.M., and Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16 (1997) 1647-1655
12. Haslekas C., Breen K., Pedersen K.W., Johannessen L.E., Stang E., and Madshus I.H. The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane. Mol Biol Cell 16 (2005) 5832-5842
13. Hendriks B.S., Opresko L.K., Wiley H.S., and Lauffenburger D. Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels. J Biol Chem 278 (2003) 23343-23351
14. Hommelgaard A.M., Lerdrup M., and van Deurs B. Association with membrane protrusions makes ErbB2 an internalization-resistant receptor. Mol Biol Cell 15 (2004) 1557-1567
15. Houimel M., Schneider P., Terskikh A., and Mach J.P. Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor. Int J Cancer 92 (2001) 748-755
16. Hudziak R.M., Lewis G.D., Winget M., Fendly B.M., Shepard H.M., and Ullrich A. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol 9 (1989) 1165-1172
17. Hurwitz E., Stancovski I., Sela M., and Yarden Y. Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. Proc Natl Acad Sci USA 92 (1995) 3353-3357
18. Jaulin-Bastard F., Saito H., Le B.A., Ollendorff V., Marchetto S., Birnbaum D., et al. The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins. J Biol Chem 276 (2001) 15256-15263
19. Karasseva N.G., Glinsky V.V., Chen N.X., Komatireddy R., and Quinn T.P. Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library. J Protein Chem 21 (2002) 287-296
20. Klapper L.N., Waterman H., Sela M., and Yarden Y. Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. Cancer Res 60 (2000) 3384-3388
21. Lenferink A.E., Pinkas-Kramarski R., van de Poll M.L., van Vugt M.J., Klapper L.N., Tzahar E., et al. Differential endocytic routing of homo-and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J 17 (1998) 3385-3397
22. Lerdrup L.N., Hommelgaard M.H., Grandal M., and Van D.B. Geldanamycin stimulates internalization of EbB2 in a proteasome-dependent way. J Cell Sci 119 (2006) 85-95
23. Lerdrup M., Bruun S., Grandal M.V., Roepstorff K., Kristensen M.M., Hommelgaard A.M., and van Deurs B. Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus. Mol Biol Cell 18 (2007) 3656-3666
24. Lewis G.D., Lofgren J.A., McMurtrey A.E., Nuijens A., Fendly B.M., Bauer K.D., et al. Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res 56 (1996) 1457-1465
25. Maier L.A., Xu F.J., Hester S., Boyer C.M., McKenzie S., Bruskin A.M., et al. Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2. Cancer Res 51 (1991) 5361-5369
26. Mukherjee S., Ghosh R.N., and Maxfield F.R. Endocytosis. Physiol Rev 77 (1997) 759-803
27. Muthuswamy S.K., Li D., Lelievre S., Bissell M.J., and Brugge J.S. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 3 (2001) 785-792
28. Nagaoka T, Fukuda T, Hashizume T, Nishiyama T, Tada H, Yamada H, et al. A betacellulin mutant promotes differentiation of pancreatic acinar AR42J cells into insulin producing cells with low affinity of binding to ErbB1. J Mol Biol, in press.
29. Olayioye M.A., Neve R.M., Lane H.A., and Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19 (2000) 3159-3167
30. Pierce J.H., Arnstein P., DiMarco E., Artrip J., Kraus M.H., Lonardo F., et al. Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6 7 (1991) 1189-1194
31. Pero S.C., Shukla G.S., Armstrong A.L., Peterson D., Fuller S.P., Godin K., et al. Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells. Int J Cancer 111 (2004) 951-960
32. Ross J.S., and Fletcher J.A. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells 16 (1998) 413-428
33. Salomon D.S., Brandt R., Ciardiello F., and Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19 (1995) 183-232
34. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
35. Sorkin A., Di Fiore P.P., and Carpenter G. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. Oncogene 8 (1993) 3021-3028
36. Sorkin A., and Waters C.M. Endocytosis of growth factor receptors. Bioessays 15 (1993) 375-382
37. Tikhomirov O., and Carpenter G. Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation. J Biol Chem 275 (2000) 26625-26631
38. Tuoya, Hirayama K., Nagaoka T., Yu D., Fukuda T., Tada H., et al. Identification of cell surface marker candidates on SV-T2 cells using DNA microarray on DLC-coated glass. Biochem Biophys Res Commun 334 (2005) 263-268
39. Tzahar E., Waterman H., Chen X., Levkowitz G., Karunagaran D., Lavi S., et al. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 16 (1996) 5276-5287
40. Urbanelli L., Ronchini C., Fontana L., Menard S., Orlandi R., and Monaci P. Targeted gene transduction of mammalian cells expressing the HER2/neu receptor by filamentous phage. J Mol Biol 313 (2001) 965-976
41. Wang Z., Zhang L., Yeung T.K., and Chen X. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol Biol Cell 10 (1999) 1621-1636
42. Watanabe T., Seno M., Sasada R., and Igarashi K. Molecular characterization of recombinant human acidic fibroblast growth factor produced in E. coli: comparative studies with human basic fibroblast growth factor. Mol Endocrinol 4 (1990) 869-879
43. Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology 61 (2001) 1-13
44. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2 (2001) 127-137
45. Zhang X., Silva E., Gershenson D., and Hung M.C. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. Oncogene 4 (1989) 985-989